ZYDUS LIFESCIENCES
Back to Balance Sheet
|
ZYDUS LIFESCIENCES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹-1,198 Cr | ₹-1,068 Cr | ₹-942 Cr | ₹-955 Cr | ₹-643 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of ZYDUS LIFESCIENCES ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | ₹-1,198 Cr |
Mar2023 | ₹-1,068 Cr |
Mar2022 | ₹-942 Cr |
Mar2021 | ₹-955 Cr |
Mar2020 | ₹-643 Cr |
How is Deferred Tax Assets / Liabilities of ZYDUS LIFESCIENCES Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹-1,198 Cr | Negative | |
Mar2023 | ₹-1,068 Cr | Negative | |
Mar2022 | ₹-942 Cr | Negative | |
Mar2021 | ₹-955 Cr | Negative | |
Mar2020 | ₹-643 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of ZYDUS LIFESCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ZYDUS LIFESCIENCES | ₹88,530.5 Cr | 5.8% | -4% | -5.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹432,960.0 Cr | 3.1% | 3.1% | 17.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹165,003.0 Cr | 10.2% | 6.7% | 61.3% | Stock Analytics | |
CIPLA | ₹125,289.0 Cr | 2.4% | 2.5% | 14% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹112,508.0 Cr | 2.1% | 2.9% | 31.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹100,256.0 Cr | 3.2% | 1.3% | -0.2% | Stock Analytics |
ZYDUS LIFESCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ZYDUS LIFESCIENCES | 5.8% |
-4% |
-5.9% |
SENSEX | 3.6% |
5.8% |
10.1% |
You may also like the below Video Courses